Ayala Pharmaceuticals, Inc.

ADXSOTCHealthcare

$0.60

+$0.00(+0.00%)

Market Cap$25707577

P/E Ratio—

52W High$0.801

52W Low$0.0011

Avg Volume5K

Open$0.10

Beta-4.03

Overview

Ayala Pharmaceuticals, Inc. (ADXS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ADXS · cash on hand · updated Dec 31, 2023

Core cash position

as of Dec 31, 2023

Cash & Short-Term Investments (CCE + ST Investments)

$4.9M▼ -80.6% vs prior year

FY · as of Dec 31, 2023 · Reported in USD

Cash & Cash Equiv. (CCE)

$4.9M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-80.6%

vs prior fiscal year

Latest Quarter

$4.9M

Q4 2023

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$4.9MCash on Hand

Total Debt$8.3MTotal Debt

Net Cash / Net Debt−$3.4MNet Debt Position

Cash vs Debt Ratio

Cash 37%Ayala Pharmaceuticals, Inc. cash as % of market cap: 18.99%% · MCap $0BDebt 63%

Ayala Pharmaceuticals, Inc. carries a net debt position of $3.4M. Total debt ($8.3M) exceeds cash on hand ($4.9M). Ayala Pharmaceuticals, Inc. cash vs debt ratio: 37% cash / 63% debt.

Net Cash = Cash & ST Investments − Total Debt$4.9M − $8.3M = −$3.4M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ADXS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ADXS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2023LatestFY$4.9M-80.6%

Dec 31, 2022FY$25.2M-39.4%

Jan 31, 2022FY$41.6M+65.3%

Jan 31, 2021FY$25.2M+50.5%

Jan 31, 2020FY$16.7M-62.1%

ADXS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ADXS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Ayala Pharmaceuticals, Inc.YOU

ADXS

$4.9M$26M19.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Ayala Pharmaceuticals, Inc. (ADXS) cash on hand as of December 31, 2023 is $4.9M, comprising $4.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Ayala Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Ayala Pharmaceuticals, Inc. cash reserves or cash position.

Ayala Pharmaceuticals, Inc. annual cash on hand history shows decreased -80.6% in 2023: decreased -80.6% in 2023. Ayala Pharmaceuticals, Inc. cash reserves in 2023 reflect the company's capital allocation strategy.

Ayala Pharmaceuticals, Inc. carries total debt of $8.3M against cash of $4.9M, resulting in a net debt position of -$3.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ADXS cash on hand · 5 questions

As of December 31, 2023, Ayala Pharmaceuticals, Inc. (ADXS) has $4,882,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4,882,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2023): $4,882,000. Data sourced from the annual 10-K filing via FMP.

ADXS cash on handADXS cash reservesADXS cash 2023how much cash does ADXS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Ayala Pharmaceuticals, Inc. · Ayala Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023